Procurement contracts for COVID-19 vaccines
During the COVID-19 pandemic, the federal government procured vaccines from different manufacturers at an early stage to protect the public. It was therefore able to secure rapid access to effective COVID-19 vaccines for people in Switzerland. It focused on mRNA vaccines, supplemented with other vaccines.
The contracts on the procurement of COVID-19 vaccines are disclosed in line with the requirements of the Federal Act on Freedom of Information in the Administration (FoIA). For further information on the disclosure, see Procurement of Covid-19 vaccines
All contracts and agreements are drafted in English and are therefore only available in English.
Published contractual documents
Please note: personal data remains redacted in all documents.
AstraZeneca AG
CureVac Corporate Services GmbH
Moderna Switzerland GmbH
Novavax Inc. USA
Contractual documents relating to other manufacturers
The following contracts on the procurement of COVID-19 vaccines with other manufacturers were disclosed in 2022 in line with the requirements of the Federal Act on Freedom of Information in the Administration (FoIA) in partly redacted form (protection of manufacturers’ business or manufacturing secrets). These are currently the subject of ongoing legal proceedings.
Pfizer AG
Janssen Pharmaceutica NV
Further topics
Procurement of Covid-19 vaccines
During the Covid-19 pandemic, the federal authorities adopted a safety-oriented vaccine strategy. Accordingly, they procured vaccines from various manufacturers at an early stage, thus ensuring rapid access to effective vaccines for the Swiss population.
Federal Office of Public Health FOPH
Schwarzenburgstrasse 157
Switzerland - 3003 Bern